期刊文献+

L-去氧肾上腺素合成研究进展 被引量:4

Research progress in the synthesis of L-phenylephrine
下载PDF
导出
摘要 L-去氧肾上腺素是一种α1受体激动药物,具有血管收缩作用,在临床中应用广泛,并呈稳定的增长趋势。国内外对于合成L-去氧肾上腺素的报道较多,但多为专利且年代跨度大,缺乏系统的综述。本文综述了国内外合成L-去氧肾上腺素的各种工艺路线及最新研究成果,按拆分法和不对称合成法归类,对各合成方法的优缺点进行了评述。传统的拆分法随着消旋体合成工艺的革新、动态动力学拆分等新技术的应用,在L-去氧肾上腺素的生产中将继续发挥作用。化学不对称合成经过近三十年的研究,已成为制备L-去氧肾上腺素药物最经济、有效的合成手段,并保持良好的发展态势。生物不对称合成技术将逐步从实验室和基础研究步入到应用阶段,今后在L-去氧肾上腺素的合成中,将占有十分重要的地位。 L-phenylephrine is anα1 receptor agonist drug,with vasoconstriction,which is widely used in clinical practice,and its market demand shows a trend of steady growth. Some synthesis methods of L-phenylephrine were reported at home and abroad. However,most of these reports are patents and apart from each other,lack of systematic review. The paper is aimed to summarize various routes for the synthesis of L-phenylephrine and the latest research results,then divides them into two categories, split method and asymmetric synthesis. Both the advantages and disadvantages of each method are reviewed. The traditional split method will continue to play an important role in the production of L-phenylephrine with the racemic synthesis process innovation and the application of new technologies,such as dynamic kinetic resolution. Chemical asymmetric synthesis,after nearly 30 years of research,has been the most economical and effective mean to prepare L-phenylephrine drug,and maintains a good momentum of development. Biological asymmetric synthesis technology will develop gradually from the lab and basic research into application stage. It will occupy a very important position in the synthesis of L-phenylephrine in the future.
出处 《化工进展》 EI CAS CSCD 北大核心 2015年第11期4035-4046,共12页 Chemical Industry and Engineering Progress
关键词 L-去氧肾上腺素 催化剂 选择性 合成 生物催化 L-phenylephrine catalyst selective synthesis biocatalysis
  • 相关文献

参考文献53

  • 1Qin Y H, Guillory J K, Schoenwald R D. Formulation, in vitro dissolution, and ocular bioavailability of high- and low-melting phenylephrineoxazolidines[J].PharmaceuticalResearch, 1993, 10 (11): 1627-1631.
  • 2Dewani A P, Dabhade S M, Bakal R L. Development and validation of a novel RP-HPLC method for simultaneous determination of paracetamol, phenylephrinehydrochloride, caffeine, cetirizineand nimesulide in tablet formulation[J]. Arabian Journal of Chemistry, 2013, 4 (5): 501-505.
  • 3王琰,陈文静,周颖,黄敏,贺文义,姚庆强,张启明,邓玉林,张玉奎.纤维素衍生物手性固定相拆分肾上腺素、盐酸去氧肾上腺素[J].药物分析杂志,2012,32(11):1985-1990. 被引量:8
  • 4金有豫.药理学[M].第5版.北京:人民卫生出版社,2001.63~64.
  • 5Ma J, Wu L N, Hou Z, et al. Visualizing the endocytosis of phenylephrine in living cells by quantum dot-based tracking[J]. Biomaterials, 2014, 35: 7042-7049.
  • 6于彩岩,李晓光,王海,李玉芳.盐酸去氧肾上腺素光学异构体测定方法研究[J].内蒙古石油化工,2010,36(4):9-10. 被引量:3
  • 7Dousa M, Gibala P, Havlicek J, et al. Drug-excipient compatibility testing-Identification and characterization of degradation products of phenylephrine in several pharmaceutical formulations against the common cold[J]. Journal of Pharmaceutical and Biomedical Anatysis,2011,55:949-956.
  • 8倪永年,桂怿.微分脉冲伏安法测定药物中盐酸去氧肾上腺素的含量[J].南昌大学学报(理科版),2009,33(1):35-37. 被引量:3
  • 9Legerlotz H. Monohydric amino alcohols and their derivatives: DE, 566578[P]. 1927-03-22.
  • 10Legerlotz H. Optically active monohydroxyphenylalkylamines: DE, 543529[P]. 1929-05-28.

二级参考文献59

共引文献80

同被引文献16

引证文献4

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部